Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Exalenz Bioscience Ltd
  6. Summary
    EXEN   IL0011048688

EXALENZ BIOSCIENCE LTD

(EXEN)
 SummaryNewsCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2018 13,1 M - -
Net income 2018 -5,50 M - -
Net Debt 2018 2,93 M - -
P/E ratio 2018 -34,6x
Yield 2018 -
Sales 2019 14,0 M - -
Net income 2019 -1,94 M - -
Net Debt 2019 3,09 M - -
P/E ratio 2019 -40,0x
Yield 2019 -
Capitalization 46,4 M 46,0 M -
EV / Sales 2018 4,24x
EV / Sales 2019 1,82x
Nbr of Employees 30
Free-Float 24,4%
More Financials
Company
Exalenz Bioscience Ltd is an Israel-based company active in the medical sector. It develops and commercializes advanced systems that extract vital information for diagnostics from subtle changes in the patient's exhaled breath. Its core technology enables medical specialists to identify and manage specific digestive and liver conditions. The Company's product, the BreathID System, is used for assessment and... 
More about the company
All news about EXALENZ BIOSCIENCE LTD
2020MERIDIAN BIOSCIENCE : Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State..
AQ
2019Exalenz Bioscience Ltd Reports Earnings Results for the Second Quarter Ended June 30, 2..
CI
2019Exalenz Bioscience Receives Approval for Commercial Marketing in China for Its Breathid..
CI
2018Exalenz Bioscience Ltd. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
2018Exalenz Bioscience Ltd Reports Financial Results for the Second Quarter and Six Months ..
CI
2018Exalenz Bioscience Ltd. Announces BreathID«13C-methacetin Breath Test
CI
2018Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer
CI
2018Exalenz Bioscience’s BreathID« Hp & BreathID Hp Lab Systems Receive FDA Clearance for D..
CI
2018Exalenz Bioscience Ltd Reports Earnings Results for the Fourth Quarter and Full Year En..
CI
2018Exalenz Bioscience Announces Positive Clinical Trial Results for the Diagnosis of Clini..
CI
2017Exalenz Bioscience Ltd Launches Automated BreathID« Hp Lab Urea Breath Testing System F..
CI
2017Exalenz Bioscience Plans For Nasdaq IPO
CI
2016Exalenz Bioscience Receives FDA Marketing Clearance for its Laboratory System in the Un..
CI
More news
News in other languages on EXALENZ BIOSCIENCE LTD

- No features available -

More news
Income Statement Evolution
Managers and Directors
RaphaŰl Werner Chief Executive Officer
Moshe Dori Chief Financial Officer
Uri Geiger Chairman
Ilan Ben Oren Chief Technology Officer
Ofer Schlesinger Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
EXALENZ BIOSCIENCE LTD107.88%46
ABBOTT LABORATORIES18.98%227 013
MEDTRONIC PLC-8.77%144 277
BECTON, DICKINSON AND COMPANY-3.42%68 717
HOYA CORPORATION28.35%57 923
DEXCOM, INC.51.53%54 298